← Leaderboards
Mariya Petrova
University Of Miami School Of Medicine
$1,169,035
Attributed
$2,978,902
Total exposure
1
Grants
0
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $1.1M · FY2022–25$2M$1.5M$1M$500K$0
'22
'23
'24
'25
Funding mix
By agency
NIH$2,978,902 · 1
By mechanism
R01$2,978,902 · 1
Top collaborators
- Jose Szapocznik3 shared
- Adam Wayne Carrico2 shared
Most similar at University Of Miami School Of Medicine
Same institution · by research overlap
- Gbenga Godwin Ogedegbe$43,167,440
- Margaret A Fischl$33,970,395
- Seble G Kassaye$24,111,544
- Daniel J Feaster$37,999,274
- Vittorio Porciatti$11,502,425
Others in their field
Other Rising Stars on “Fda Approved”
- Suma Babu · Massachusetts General Hospital$26,348,733
- Sabrina Paganoni · Massachusetts General Hospital$26,348,733
- Michael Difilippantonio · Leidos Biomedical Research, Inc.$22,364,766
- Michael George Natchus · Emory University$10,548,554
- John Alam · Eip Pharma, Inc.$10,411,018
- George Gaitanaris · Omeros Corporation$6,689,019
Research focus
Fda ApprovedLaboratoriesEffectivenessFaceHigh Risk Sexual BehaviorImprisonmentAbstinenceDiagnosisEpidemicAdultFollow-UpHealth Care SettingsBloodCaringClinicAdoptionCommunitiesAntiretroviral TherapyConsentAreaContinuity Of Patient CareCost EffectivenessDesignMaintenance
Grant awards (3)
reSET for the Treatment of Stimulant Use in HIV Clinics: Care Optimization Supporting Treatment Adherence (COSTA)$1,056,408
R01 · FY2025 · DA
reSET for the Treatment of Stimulant Use in HIV Clinics: Care Optimization Supporting Treatment Adherence (COSTA)$990,189
R01 · FY2023 · DA
reSET for the Treatment of Stimulant Use in HIV Clinics: Care Optimization Supporting Treatment Adherence (COSTA)$932,305
R01 · FY2022 · DA